Novel avenue towards liver regeneration and treatment of acute and chronic liver diseases: safety and PK profile from a first-in human (FIH) clinical trial for HRX-0215 as first in class MKK4 inhibitor
Year: 2022
Type: article
Source: Journal of Hepatology
Authors: Birgit Jung, Markus Weissbach, Michael Lutz, Roland Selig, Stefan Laufer, Lars Zender, Michael Feigh, Matthias Berse, Jette Penski, Esther Kosmella, Wolfgang Albrecht
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4283815501